Zhenfeng Chen
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Wnt/β-catenin signaling in development and cancer 2
- Inflammasome and immune disorders 2
-
- Advanced Glycation End Products research 9
- Co-authors
- Qiaobing Huang (18 shared papers)Jie Wu (5 shared papers)Maomao Sun (4 shared papers)Xiaohua Guo (15 shared papers)Liang Hong (1 shared paper)Zhenhua Zeng (3 shared papers)Zhiya Deng (2 shared papers)Shumin Cai (1 shared paper)
- Journals
- Frontiers in Physiology (3 papers)Shock (2 papers)International Immunopharmacology (2 papers)Anti-Cancer Agents in Medicinal Chemistry (1 paper)Journal of Cellular and Molecular Medicine (1 paper)
- Partner nations
- China
In The Last Decade
Zhenfeng Chen
23 papers receiving 435 citations
Peers
Comparison fields: 5 of 76
- Geriatrics and Gerontology 56
- Critical Care and Intensive Care Medicine 25
- Clinical Biochemistry 31
- Nephrology 32
- Immunology 86
Countries citing papers authored by Zhenfeng Chen
This map shows the geographic impact of Zhenfeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenfeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenfeng Chen more than expected).
Fields of papers citing papers by Zhenfeng Chen
This network shows the impact of papers produced by Zhenfeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenfeng Chen. The network helps show where Zhenfeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenfeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 135 | |
| 2 | 2022 | 75 | |
| 3 | 2019 | 50 | |
| 4 | 2010 | 35 | |
| 5 | 2018 | 32 | |
| 6 | 2022 | 14 | |
| 7 | 2020 | 13 | |
| 8 | 2018 | 13 | |
| 9 | 2021 | 12 | |
| 10 | 2024 | 10 | |
| 11 | 2024 | 7 | |
| 12 | 2024 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2024 | 5 | |
| 15 | 2022 | 4 | |
| 16 | 2024 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2024 | 2 |
About Zhenfeng Chen
Zhenfeng Chen is a scholar working on Molecular Biology, Clinical Biochemistry, Epidemiology, Immunology and Cancer Research, having authored 26 papers that have together received 438 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (9 papers), Advanced Control Systems Optimization (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Cell Adhesion Molecules Research (2 papers), Adaptive Control of Nonlinear Systems (2 papers), interferon and immune responses (2 papers), Thermal Regulation in Medicine (2 papers) and Inflammasome and immune disorders (2 papers). The work is most often cited by research in Geriatrics and Gerontology (56 citations), Critical Care and Intensive Care Medicine (25 citations), Clinical Biochemistry (31 citations), Nephrology (32 citations) and Immunology (86 citations). Zhenfeng Chen has collaborated with scholars based in China. Frequent co-authors include Qiaobing Huang, Jie Wu, Maomao Sun, Xiaohua Guo, Liang Hong, Zhenhua Zeng, Zhiya Deng, Shumin Cai, Sheng An and Cheng-Lun Wu. Their work appears in journals such as Frontiers in Physiology, Shock, International Immunopharmacology, Anti-Cancer Agents in Medicinal Chemistry and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.